Skip to content
#gene editing Review Open access

Gene therapy for epilepsy: From SCN1A to broadened therapeutic horizons (Review).

Nov 2026 · Molecular Medicine Reports · Vol 35 1 · 0 citations · 138 references
Medicine

TL;DR

Five nucleic acid‑based therapeutic strategies are examined, namely gene supplementation, enhancement of endogenous gene expression, gene silencing, DNA editing and RNA editing, for major causative genes, using mutation‑specific functional consequences [loss‑of‑function (LOF) vs. gain‑of‑function] as the primary framework for therapeutic decision‑making.

Abstract

Genetic epilepsy, for which the molecular mechanisms are relatively well defined in numerous monogenic forms, represents an attractive model for the transition from symptomatic seizure control to mechanism‑driven correction. However, gene therapy strategies differ in their mechanisms of action, adaptability to specific mutations and translational maturity, making rational selection of interventions based on variant‑specific functional consequences an important clinical challenge. The present review examined five nucleic acid‑based therapeutic strategies, namely gene supplementation, enhancement of endogenous gene expression, gene silencing, DNA editing and RNA editing, for major causative genes, using mutation‑specific functional consequences [loss‑of‑function (LOF) vs. gain‑of‑function] as the primary framework for therapeutic decision‑making. The mechanisms and suitability of each approach are analysed, and their performance in terms of cell‑type specificity, delivery vectors and safety is evaluated by integrating evidence from animal models, induced pluripotent stem cell‑derived neurons and organoids and clinical trials. The present review also summarised key translational barriers, including vector cargo constraints, blood‑brain barrier penetration, off‑target and immune‑associated risks, therapeutic dosing windows and the timing of developmental intervention. Antisense oligonucleotides and regulatory adeno‑associated viral approaches, supported by mature delivery platforms and manageable safety profiles, have progressed furthest towards clinical validation. Endogenous gene activation strategies, such as CRISPR activation, offer a gene replacement‑free approach for LOF disorders but remain preclinical. DNA and RNA editing, while potentially capable of durable disease modification, require further evidence on delivery efficiency and long‑term homeostatic safety. Gene therapy for genetic epilepsy is undergoing a key transition from proof‑of‑concept studies to individualised clinical application. Future progress will depend on integrating personalised intervention design, multi‑target therapeutic combinations, artificial intelligence‑assisted sequence optimisation and standardised translational models, with the potential to drive a paradigm shift from seizure suppression to mechanistic correction.

Read PDF

Similar papers

#computer vision Conference Aug 2008

A Preliminary Roadmap for Empirical Research on Agile Software Development

Some claim that especially in the field of agile software development the research lags years behind of the practice. In this paper, we characterize the status and main challenges for research on agile software development, and propose a preliminary roadmap, focusing on providing more empirical research, primarily on e...

Torgeir Dingsøyr, T. Dybå, P. Abrahamsson · 92 citations · ⚡7
#computer vision Book Open access Mar 2017

On the Unhappiness of Software Developers

The results indicate that software developers are a slightly happy population, but the need for limiting the unhappiness of developers remains, and 219 factors representing causes of unhappiness while developing software are identified.

D. Graziotin, Fabian Fagerholm, Xiaofeng Wang et al. · 84 citations · ⚡6
#computer vision Open access Feb 2018

Lean Internal Startups for Software Product Innovation in Large Companies: Enablers and Inhibitors

This study investigates how Lean internal startup facilitates software product innovation in large companies and identifies its enablers and inhibitors, and shows the potential of the method-in-action framework to investigate the Lean startup approach in non-startup context.

Henry Edison, Nina M. Smørsgård, Xiaofeng Wang et al. · 78 citations · ⚡6
#computer vision Review Apr 2024

AI-powered Code Review with LLMs: Early Results

The goal is to not only refine the accuracy of the LLM-based tool but also to underscore its potential in streamlining the software development lifecycle through proactive code improvement and education.

Z. Rasheed, Malik Abdul Sami, Muhammad Waseem et al. · 62 citations · ⚡3
#computer vision Conference Aug 2008

Scrum in a Multiproject Environment: An Ethnographically-Inspired Case Study on the Adoption Challenges

Agile methods continue to gain popularity. In particular, the Scrum method appears to be on the verge of becoming a de-facto standard in the industry, leading the so called Agile movement. While there are success stories and recommendations, there is little scientifically valid evidence of the challenges in the adoptio...

A. Marchenko, P. Abrahamsson · 59 citations · ⚡11

Related blog posts

Microsoft Research Blog Nov 12, 2026

Microsoft Research Focus – Edition #98

What's new in research at Microsoft? Host Anson Ho explores the latest, including AI-powered universal translation, a breakthrough in a 31-year-old mathematics challenge, and advances making AI coding agents faster and more efficient.  The post Microsoft Research Focus – Edition #98 appeared first on Microsoft Research.

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.